Management of Acute Exacerbation of Chronic Obstructive Pulmonary Disease during the COVID-19 Pandemic

Authors

  • Pratap Upadhya Department of Pulmonary Medicine, Jawaharlal Institute of Postgraduate Medical Education & Research, Puducherry, India.
  • C. Sivaselvi Department of Pulmonary Medicine, Jawaharlal Institute of Postgraduate Medical Education & Research, Puducherry, India.
  • Rohit Vadala All India Institute of Medical Sciences, New Delhi, India.
  • R. Manju Department of Pulmonary Medicine, Jawaharlal Institute of Postgraduate Medical Education & Research, Puducherry, India.

DOI:

https://doi.org/10.9734/bpi/pramr/v7/4190B

Keywords:

COVID-19, Chronic Obstructive Pulmonary Disease acute exacerbation, nebulization therapy, non-invasive ventilation

Abstract

The COVID-19 pandemic made it challenging to diagnose and treatment of Chronic Obstructive Pulmonary Disease (COPD) and increased mortality and morbidity. Treatment of COPD during acute exacerbation requires aerosolization therapy like nebulization and non-invasive ventilation modalities like high-flow nasal cannula (HFNC) and Non-invasive ventilation (NIV). Even though aerosolization therapy impacts the spread of COVID-19, with proper precaution COPD management has to be continued as per standard recommendations.

Published

2023-01-20

How to Cite

Pratap Upadhya, C. Sivaselvi, Rohit Vadala, & R. Manju. (2023). Management of Acute Exacerbation of Chronic Obstructive Pulmonary Disease during the COVID-19 Pandemic. Perspective of Recent Advances in Medical Research Vol. 7, 69–76. https://doi.org/10.9734/bpi/pramr/v7/4190B

Issue

Perspective of Recent Advances in Medical Research Vol. 7

Section

Chapters